The Perils of Dealing with Whistleblowers Under the False Claims ActSeton Hall Law U.S. Healthcare Compliance Certification Program
Blank Rome LLP Partner Nicholas C. Harbist will be speaking on “The Perils of Dealing with Whistleblowers Under the False Claims Act” at Seton Hall Law’s U.S. Healthcare Compliance Certification Program, on June 12, 2017, from 4:05 p.m. to 5:30 p.m.
The four-day healthcare compliance program is scheduled for June 12-17, 2017, and will host Seton Hall Law School faculty and respected industry leaders for a comprehensive overview of state, federal, and international law governing prescription drugs and medical devices.
Featured program topics include:
- Data Privacy – HIPAA, HITECH, and others
- FDA approval and regulation of new drugs and devices
- Federal Anti-Kickback Statute
- Federal and State False Claims Acts
- Federal Sunshine Law
- Foreign Corrupt Practices Act, including worldwide anti-corruption and enforcement
- Government investigations
- Healthcare fraud sentencing, penalties, damages, and other considerations
- OIG Compliance
- Prescription drug and device marketing and advertising
Throughout the program, attendees will be presented with the statutes, regulations, and other guidance that comprise the body of law known as “fraud and abuse law,” and will examine healthcare-related laws and regulations alongside other compliance, ethics and integrity officers, legal counsel, healthcare consultants, and regulatory and medical affairs professionals. Attendees will also engage in group problem-solving activities and analyze the covered laws and regulations through case studies. By the program’s conclusion, attendees will discover how to create a culture of compliance and leave with the skills necessary to develop, enhance, and enforce their organization’s corporate compliance program.
To learn more or to register to attend, please click here.